Stapled lipopeptides show promise as broad-spectrum antiviral agents

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

Related Keywords

Dana Farber Cancer Institute ,Massachusetts ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Boston University ,Richard Bowen ,Aaron Moss ,Loren Walensky ,Robert Davey ,Massachusetts Consortium On Pathogen Readiness ,Microbiology At Boston University ,Boston University National Emerging Infectious Diseases Laboratories ,Colorado State University ,National Institutes Of Health ,Blood Disorders Center ,Nature Communications ,Farber Cancer ,Principal Investigator ,Linde Program ,Cancer Chemical Biology ,Boston Children ,Blood Disorders ,Gregory Bird ,Red Queen Therapeutics ,Queen Therapeutics ,Red Queen ,Massachusetts Consortium ,Pathogen Readiness ,National Institutes ,Pre Clinical Services Program ,National Institute ,Infectious Diseases ,Colorado State ,Compound ,Covid 19 ,Virus ,Antibodies ,Flood ,Dancer ,Fell ,Children ,Clinical Trial ,Coronavirus ,Drugs ,Revolution ,Felix ,Lungs ,Embrane ,Olecule ,Nasal Spray ,Pandemic ,Eptides ,Prophylaxis ,Research ,Espiratory ,Cars ,Ars Cov 2 ,Technology ,Herapeutics ,